The case for a lower dose pill. Assessing the impact of estrogen dose.
D000367:Age Factors; D001695:Biology; D001769:Blood; D001777:Blood Coagulation; D016022:Case-Control Studies; D002560:Cerebrovascular Circulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003710:Demography; D003718:Denmark; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D004703:Endocrine System; D004967:Estrogens; D005060:Europe; D005193:Family Planning Services; D006728:Hormones; D007558:Italy; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D045167:Progesterone Congeners; D012189:Retrospective Studies; D012537:Scandinavian and Nordic Countries; D013923:Thromboembolism; D013927:Thrombosis; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004967:Estrogens; D006728:Hormones; D045167:Progesterone Congeners
Age Factors; Biology; Blood Coagulation Effects; Case Control Studies; Cerebrovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Demographic Factors; Denmark; Developed Countries; Diseases; Embolism; Endocrine System; Estrogens; Europe; Family Planning; Hematological Effects; Hemic System; Hormones; Italy; Mediterranean Countries; Northern Europe; Oral Contraceptives, Low-dose--side effects; Oral Contraceptives--side effects; Physiology; Population; Population Characteristics; Progestins, Low-dose; Retrospective Studies; Scandinavia; Southern Europe; Studies; Thromboembolism; Thrombosis; Vascular Diseases